Total Quality
Score
If You Had Traded on This Analysis…
Fail
NVO
Long Entry
49.0250
2025-11-20
00:00 UTC
Target
70.0000
Fail
40.0000
In 3 Months
Risk/Reward
1 : 2
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
Final PnL
-18.41%
P/L: —
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
The video discusses Novo Nordisk stock, indicating that analysts rate it a moderate buy, with an average score of 3.71 out of 5, improved from 3.33 over the last 3 months. The high target price is $70, which suggests a 52% potential upside. Wall Street is betting on a rebound, suggesting the analysis is bullish.